C.H. Boehringer Sohn AG & Co. KG

C.H. Boehringer Sohn AG & Co. KG

C.H. Boehringer Sohn AG & Co. KG

Overview
Date Founded

1894

Headquarters

Binger Strasse 173,Ingelheim am Rhein, Rheinland-Pfalz 55216

Type of Company

Private

Industries

Pharmaceuticals
Holding Companies

Company Description

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Website

http://www.boehringer-ingelheim.com

In The News
GlobeNewswire
January 13, 2021
Veterinary Medicine Market Research Report by Mode of Delivery, by Product, by Animal Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
PR Newswire
January 11, 2021
Global $1.78 Bn Rituximab Biosimilars Forecast Market, 2019-2023F, 2025F & 2030F
GlobeNewswire
January 7, 2021
Global Rituximab Biosimilars Market Report 2020-2030: COVID-19 Impacts, Growth and Change
Business Wire
November 10, 2020
The Animal Healthcare Market 2020-2024 - Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Cadila Healthcare Ltd., Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Opportunities and Forecast 2024 | Technavio
Business Wire
October 26, 2020
Global Animal Healthcare Market - Featuring Bayer AG, C. H. Boehringer Sohn AG & Co. KG, and Cadila Healthcare Ltd. Among Others | Technavio

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Hermann Bühlbecker

Professional

Board of Directors
Christian Boehringer

Chairman-Supervisory Board at Boehringer Ingelheim GmbH

Trending People
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Trending Organizations
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Paths to C.H. Boehringer Sohn AG & Co. KG
Potential Connections via
Relationship Science
You
C.H. Boehringer Sohn AG & Co. KG
Recent Transactions
Details Hidden

C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim International GmbH purchase Northern Biologics, Inc.

Details Hidden

C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim International GmbH purchase Amal Therapeutics SA from Schroder Adveq Management AG, VI Partners AG, High-Tech Gründerfonds Management GmbH, BioMedPartners AG, Boehringer Ingelheim Venture, Helsinn Healthcare SA /Venture

Details Hidden

Dopharma BV, Stichting Administratiekantoor Dopharma Holding purchase Boehringer Ingelheim France SAS /Saint Herblon Factory from C.H. Boehringer Sohn AG & Co. KG

Transaction Advisors
Investment Advisor
Bank of America Merrill Lynch

Advised onBoehringer Ingelheim GmbH, C.H. Boehringer Sohn AG & Co. KG purchase Merial SAS from Sanofi

Investment Advisor
Rothschild Holding AG

Advised onBoehringer Ingelheim GmbH, C.H. Boehringer Sohn AG & Co. KG purchase Merial SAS from Sanofi

Legal Advisor
Jones Day

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Legal Advisor
David Fox

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Legal Advisor
Patrick Jacobs

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Legal Advisor
Sean D. Rodgers

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Clients
Covetrus, Inc.

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.

BeiGene Ltd.

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Lupin Ltd.

Lupin Ltd. engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.
Investments
Details Hidden
Vitae Pharmaceuticals LLC

Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company. Its focuses on discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA.

Suppliers
Model N, Inc. IT Consulting & Services | Redwood City, CA

Model N, Inc. engages in the provision of revenue management cloud solutions for the life science and technology industries. Its solutions include two complementary suites of software applications: Revenue Management Enterprise and Revenue Management Intelligence. The Revenue Management Enterprise suite serves as the system of record for and automates the execution of revenue management processes such as pricing, contracting and incentive & rebate management. The Revenue Management Intelligence suite provides analytical insights to define and optimize revenue management strategies. The company was founded by Yarden Malka, Zack Rinat and Ali Tore on December 14, 1999 and is headquartered in San Mateo, CA.

Zealand Pharma A/S Pharmaceuticals | Soborg, Denmark

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.

Anika Therapeutics, Inc. Industrial Machinery & Manufacturing | Bedford, MA

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by C.H. Boehringer Sohn AG & Co. KG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of C.H. Boehringer Sohn AG & Co. KG's profile does not indicate a business or promotional relationship of any kind between RelSci and C.H. Boehringer Sohn AG & Co. KG.